Frontiers in Immunology (May 2022)
FOXO Dictates Initiation of B Cell Development and Myeloid Restriction in Common Lymphoid Progenitors
- Lucía Peña-Pérez,
- Lucía Peña-Pérez,
- Shabnam Kharazi,
- Shabnam Kharazi,
- Nicolai Frengen,
- Nicolai Frengen,
- Aleksandra Krstic,
- Aleksandra Krstic,
- Thibault Bouderlique,
- Thibault Bouderlique,
- Julia Hauenstein,
- Julia Hauenstein,
- Minghui He,
- Ece Somuncular,
- Ece Somuncular,
- Xiaoze Li Wang,
- Xiaoze Li Wang,
- Carin Dahlberg,
- Charlotte Gustafsson,
- Charlotte Gustafsson,
- Ann-Sofie Johansson,
- Ann-Sofie Johansson,
- Julian Walfridsson,
- Julian Walfridsson,
- Nadir Kadri,
- Petter Woll,
- Petter Woll,
- Marcin Kierczak,
- Hong Qian,
- Hong Qian,
- Lisa Westerberg,
- Sidinh Luc,
- Sidinh Luc,
- Robert Månsson,
- Robert Månsson,
- Robert Månsson
Affiliations
- Lucía Peña-Pérez
- Center for Hematology and Regenerative Medicine, Karolinska Institutet, Stockholm, Sweden
- Lucía Peña-Pérez
- Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden
- Shabnam Kharazi
- Center for Hematology and Regenerative Medicine, Karolinska Institutet, Stockholm, Sweden
- Shabnam Kharazi
- Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden
- Nicolai Frengen
- Center for Hematology and Regenerative Medicine, Karolinska Institutet, Stockholm, Sweden
- Nicolai Frengen
- Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden
- Aleksandra Krstic
- Center for Hematology and Regenerative Medicine, Karolinska Institutet, Stockholm, Sweden
- Aleksandra Krstic
- Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden
- Thibault Bouderlique
- Center for Hematology and Regenerative Medicine, Karolinska Institutet, Stockholm, Sweden
- Thibault Bouderlique
- Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden
- Julia Hauenstein
- Center for Hematology and Regenerative Medicine, Karolinska Institutet, Stockholm, Sweden
- Julia Hauenstein
- Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden
- Minghui He
- Department of Microbiology Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden
- Ece Somuncular
- Center for Hematology and Regenerative Medicine, Karolinska Institutet, Stockholm, Sweden
- Ece Somuncular
- Department of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden
- Xiaoze Li Wang
- Center for Hematology and Regenerative Medicine, Karolinska Institutet, Stockholm, Sweden
- Xiaoze Li Wang
- Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden
- Carin Dahlberg
- Department of Microbiology Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden
- Charlotte Gustafsson
- Center for Hematology and Regenerative Medicine, Karolinska Institutet, Stockholm, Sweden
- Charlotte Gustafsson
- Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden
- Ann-Sofie Johansson
- Center for Hematology and Regenerative Medicine, Karolinska Institutet, Stockholm, Sweden
- Ann-Sofie Johansson
- Department of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden
- Julian Walfridsson
- Center for Hematology and Regenerative Medicine, Karolinska Institutet, Stockholm, Sweden
- Julian Walfridsson
- Department of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden
- Nadir Kadri
- Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden
- Petter Woll
- Center for Hematology and Regenerative Medicine, Karolinska Institutet, Stockholm, Sweden
- Petter Woll
- Department of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden
- Marcin Kierczak
- Department of Cell and Molecular Biology, National Bioinformatics Infrastructure Sweden, Science for Life Laboratory, Uppsala University, Uppsala, Sweden
- Hong Qian
- Center for Hematology and Regenerative Medicine, Karolinska Institutet, Stockholm, Sweden
- Hong Qian
- Department of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden
- Lisa Westerberg
- Department of Microbiology Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden
- Sidinh Luc
- Center for Hematology and Regenerative Medicine, Karolinska Institutet, Stockholm, Sweden
- Sidinh Luc
- Department of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden
- Robert Månsson
- Center for Hematology and Regenerative Medicine, Karolinska Institutet, Stockholm, Sweden
- Robert Månsson
- Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden
- Robert Månsson
- Hematology Center, Karolinska University Hospital, Stockholm, Sweden
- DOI
- https://doi.org/10.3389/fimmu.2022.880668
- Journal volume & issue
-
Vol. 13
Abstract
The development of B cells relies on an intricate network of transcription factors critical for developmental progression and lineage commitment. In the B cell developmental trajectory, a temporal switch from predominant Foxo3 to Foxo1 expression occurs at the CLP stage. Utilizing VAV-iCre mediated conditional deletion, we found that the loss of FOXO3 impaired B cell development from LMPP down to B cell precursors, while the loss of FOXO1 impaired B cell commitment and resulted in a complete developmental block at the CD25 negative proB cell stage. Strikingly, the combined loss of FOXO1 and FOXO3 resulted in the failure to restrict the myeloid potential of CLPs and the complete loss of the B cell lineage. This is underpinned by the failure to enforce the early B-lineage gene regulatory circuitry upon a predominantly pre-established open chromatin landscape. Altogether, this demonstrates that FOXO3 and FOXO1 cooperatively govern early lineage restriction and initiation of B-lineage commitment in CLPs.
Keywords
- B cell
- FOXO (forkhead box protein O)
- lineage commitment/specification
- myeloid restriction
- gene regulation